Global Human Low-Pass Whole Genome Sequencing Supply, Demand and Key Producers, 2023-2029
The global Human Low-Pass Whole Genome Sequencing market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Human low-pass whole-genome sequencing is generally defined as sequencing the genome. Combined with genotype imputation, it provides an alternative to genotyping arrays for trait mapping and polygenic score calculations.
This report studies the global Human Low-Pass Whole Genome Sequencing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Low-Pass Whole Genome Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Low-Pass Whole Genome Sequencing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Low-Pass Whole Genome Sequencing total market, 2018-2029, (USD Million)
Global Human Low-Pass Whole Genome Sequencing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Human Low-Pass Whole Genome Sequencing total market, key domestic companies and share, (USD Million)
Global Human Low-Pass Whole Genome Sequencing revenue by player and market share 2018-2023, (USD Million)
Global Human Low-Pass Whole Genome Sequencing total market by Type, CAGR, 2018-2029, (USD Million)
Global Human Low-Pass Whole Genome Sequencing total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Human Low-Pass Whole Genome Sequencing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BGI, Breda Genetics, Azenta Life Sciences, Thermo Fisher Scientific, Psomagen, Healgen Scientific, Agilent Technologies, Macrogen and Veritas Genetics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Low-Pass Whole Genome Sequencing market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Low-Pass Whole Genome Sequencing Market, By Region:
1. How big is the global Human Low-Pass Whole Genome Sequencing market?
2. What is the demand of the global Human Low-Pass Whole Genome Sequencing market?
3. What is the year over year growth of the global Human Low-Pass Whole Genome Sequencing market?
4. What is the total value of the global Human Low-Pass Whole Genome Sequencing market?
5. Who are the major players in the global Human Low-Pass Whole Genome Sequencing market?
6. What are the growth factors driving the market demand?
Human low-pass whole-genome sequencing is generally defined as sequencing the genome. Combined with genotype imputation, it provides an alternative to genotyping arrays for trait mapping and polygenic score calculations.
This report studies the global Human Low-Pass Whole Genome Sequencing demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Low-Pass Whole Genome Sequencing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Low-Pass Whole Genome Sequencing that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Low-Pass Whole Genome Sequencing total market, 2018-2029, (USD Million)
Global Human Low-Pass Whole Genome Sequencing total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Human Low-Pass Whole Genome Sequencing total market, key domestic companies and share, (USD Million)
Global Human Low-Pass Whole Genome Sequencing revenue by player and market share 2018-2023, (USD Million)
Global Human Low-Pass Whole Genome Sequencing total market by Type, CAGR, 2018-2029, (USD Million)
Global Human Low-Pass Whole Genome Sequencing total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Human Low-Pass Whole Genome Sequencing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BGI, Breda Genetics, Azenta Life Sciences, Thermo Fisher Scientific, Psomagen, Healgen Scientific, Agilent Technologies, Macrogen and Veritas Genetics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Low-Pass Whole Genome Sequencing market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Low-Pass Whole Genome Sequencing Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
- Small Human Low-Through Whole Genome Sequencing (? 5 Mb)
- Medical
- Scientific Research
- Others
- BGI
- Breda Genetics
- Azenta Life Sciences
- Thermo Fisher Scientific
- Psomagen
- Healgen Scientific
- Agilent Technologies
- Macrogen
- Veritas Genetics
- Centogene
- Nebula Genomics
- CD Genomics
1. How big is the global Human Low-Pass Whole Genome Sequencing market?
2. What is the demand of the global Human Low-Pass Whole Genome Sequencing market?
3. What is the year over year growth of the global Human Low-Pass Whole Genome Sequencing market?
4. What is the total value of the global Human Low-Pass Whole Genome Sequencing market?
5. Who are the major players in the global Human Low-Pass Whole Genome Sequencing market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Human Low-Pass Whole Genome Sequencing Introduction
1.2 World Human Low-Pass Whole Genome Sequencing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Human Low-Pass Whole Genome Sequencing Total Market by Region (by Headquarter Location)
1.3.1 World Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.3 China Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.4 Europe Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.5 Japan Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.6 South Korea Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.7 ASEAN Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.8 India Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Low-Pass Whole Genome Sequencing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Low-Pass Whole Genome Sequencing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.2 World Human Low-Pass Whole Genome Sequencing Consumption Value by Region
2.2.1 World Human Low-Pass Whole Genome Sequencing Consumption Value by Region (2018-2023)
2.2.2 World Human Low-Pass Whole Genome Sequencing Consumption Value Forecast by Region (2024-2029)
2.3 United States Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.4 China Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.5 Europe Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.6 Japan Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.7 South Korea Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.8 ASEAN Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.9 India Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
3 WORLD HUMAN LOW-PASS WHOLE GENOME SEQUENCING COMPANIES COMPETITIVE ANALYSIS
3.1 World Human Low-Pass Whole Genome Sequencing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Human Low-Pass Whole Genome Sequencing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Human Low-Pass Whole Genome Sequencing in 2022
3.2.3 Global Concentration Ratios (CR8) for Human Low-Pass Whole Genome Sequencing in 2022
3.3 Human Low-Pass Whole Genome Sequencing Company Evaluation Quadrant
3.4 Human Low-Pass Whole Genome Sequencing Market: Overall Company Footprint Analysis
3.4.1 Human Low-Pass Whole Genome Sequencing Market: Region Footprint
3.4.2 Human Low-Pass Whole Genome Sequencing Market: Company Product Type Footprint
3.4.3 Human Low-Pass Whole Genome Sequencing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Human Low-Pass Whole Genome Sequencing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Human Low-Pass Whole Genome Sequencing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Human Low-Pass Whole Genome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Human Low-Pass Whole Genome Sequencing Consumption Value Comparison
4.2.1 United States VS China: Human Low-Pass Whole Genome Sequencing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Low-Pass Whole Genome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Human Low-Pass Whole Genome Sequencing Companies and Market Share, 2018-2023
4.3.1 United States Based Human Low-Pass Whole Genome Sequencing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023)
4.4 China Based Companies Human Low-Pass Whole Genome Sequencing Revenue and Market Share, 2018-2023
4.4.1 China Based Human Low-Pass Whole Genome Sequencing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023)
4.5 Rest of World Based Human Low-Pass Whole Genome Sequencing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Human Low-Pass Whole Genome Sequencing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Low-Pass Whole Genome Sequencing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
5.2.2 Small Human Low-Through Whole Genome Sequencing (? 5 Mb)
5.3 Market Segment by Type
5.3.1 World Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023)
5.3.2 World Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2029)
5.3.3 World Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Low-Pass Whole Genome Sequencing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Medical
6.2.2 Scientific Research
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023)
6.3.2 World Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2029)
6.3.3 World Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 BGI
7.1.1 BGI Details
7.1.2 BGI Major Business
7.1.3 BGI Human Low-Pass Whole Genome Sequencing Product and Services
7.1.4 BGI Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 BGI Recent Developments/Updates
7.1.6 BGI Competitive Strengths & Weaknesses
7.2 Breda Genetics
7.2.1 Breda Genetics Details
7.2.2 Breda Genetics Major Business
7.2.3 Breda Genetics Human Low-Pass Whole Genome Sequencing Product and Services
7.2.4 Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Breda Genetics Recent Developments/Updates
7.2.6 Breda Genetics Competitive Strengths & Weaknesses
7.3 Azenta Life Sciences
7.3.1 Azenta Life Sciences Details
7.3.2 Azenta Life Sciences Major Business
7.3.3 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Product and Services
7.3.4 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Azenta Life Sciences Recent Developments/Updates
7.3.6 Azenta Life Sciences Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Product and Services
7.4.4 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Psomagen
7.5.1 Psomagen Details
7.5.2 Psomagen Major Business
7.5.3 Psomagen Human Low-Pass Whole Genome Sequencing Product and Services
7.5.4 Psomagen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Psomagen Recent Developments/Updates
7.5.6 Psomagen Competitive Strengths & Weaknesses
7.6 Healgen Scientific
7.6.1 Healgen Scientific Details
7.6.2 Healgen Scientific Major Business
7.6.3 Healgen Scientific Human Low-Pass Whole Genome Sequencing Product and Services
7.6.4 Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Healgen Scientific Recent Developments/Updates
7.6.6 Healgen Scientific Competitive Strengths & Weaknesses
7.7 Agilent Technologies
7.7.1 Agilent Technologies Details
7.7.2 Agilent Technologies Major Business
7.7.3 Agilent Technologies Human Low-Pass Whole Genome Sequencing Product and Services
7.7.4 Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Agilent Technologies Recent Developments/Updates
7.7.6 Agilent Technologies Competitive Strengths & Weaknesses
7.8 Macrogen
7.8.1 Macrogen Details
7.8.2 Macrogen Major Business
7.8.3 Macrogen Human Low-Pass Whole Genome Sequencing Product and Services
7.8.4 Macrogen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Macrogen Recent Developments/Updates
7.8.6 Macrogen Competitive Strengths & Weaknesses
7.9 Veritas Genetics
7.9.1 Veritas Genetics Details
7.9.2 Veritas Genetics Major Business
7.9.3 Veritas Genetics Human Low-Pass Whole Genome Sequencing Product and Services
7.9.4 Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Veritas Genetics Recent Developments/Updates
7.9.6 Veritas Genetics Competitive Strengths & Weaknesses
7.10 Centogene
7.10.1 Centogene Details
7.10.2 Centogene Major Business
7.10.3 Centogene Human Low-Pass Whole Genome Sequencing Product and Services
7.10.4 Centogene Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Centogene Recent Developments/Updates
7.10.6 Centogene Competitive Strengths & Weaknesses
7.11 Nebula Genomics
7.11.1 Nebula Genomics Details
7.11.2 Nebula Genomics Major Business
7.11.3 Nebula Genomics Human Low-Pass Whole Genome Sequencing Product and Services
7.11.4 Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Nebula Genomics Recent Developments/Updates
7.11.6 Nebula Genomics Competitive Strengths & Weaknesses
7.12 CD Genomics
7.12.1 CD Genomics Details
7.12.2 CD Genomics Major Business
7.12.3 CD Genomics Human Low-Pass Whole Genome Sequencing Product and Services
7.12.4 CD Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 CD Genomics Recent Developments/Updates
7.12.6 CD Genomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Low-Pass Whole Genome Sequencing Industry Chain
8.2 Human Low-Pass Whole Genome Sequencing Upstream Analysis
8.3 Human Low-Pass Whole Genome Sequencing Midstream Analysis
8.4 Human Low-Pass Whole Genome Sequencing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Human Low-Pass Whole Genome Sequencing Introduction
1.2 World Human Low-Pass Whole Genome Sequencing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Human Low-Pass Whole Genome Sequencing Total Market by Region (by Headquarter Location)
1.3.1 World Human Low-Pass Whole Genome Sequencing Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.3 China Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.4 Europe Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.5 Japan Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.6 South Korea Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.7 ASEAN Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.3.8 India Human Low-Pass Whole Genome Sequencing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Low-Pass Whole Genome Sequencing Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Low-Pass Whole Genome Sequencing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.2 World Human Low-Pass Whole Genome Sequencing Consumption Value by Region
2.2.1 World Human Low-Pass Whole Genome Sequencing Consumption Value by Region (2018-2023)
2.2.2 World Human Low-Pass Whole Genome Sequencing Consumption Value Forecast by Region (2024-2029)
2.3 United States Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.4 China Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.5 Europe Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.6 Japan Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.7 South Korea Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.8 ASEAN Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
2.9 India Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029)
3 WORLD HUMAN LOW-PASS WHOLE GENOME SEQUENCING COMPANIES COMPETITIVE ANALYSIS
3.1 World Human Low-Pass Whole Genome Sequencing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Human Low-Pass Whole Genome Sequencing Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Human Low-Pass Whole Genome Sequencing in 2022
3.2.3 Global Concentration Ratios (CR8) for Human Low-Pass Whole Genome Sequencing in 2022
3.3 Human Low-Pass Whole Genome Sequencing Company Evaluation Quadrant
3.4 Human Low-Pass Whole Genome Sequencing Market: Overall Company Footprint Analysis
3.4.1 Human Low-Pass Whole Genome Sequencing Market: Region Footprint
3.4.2 Human Low-Pass Whole Genome Sequencing Market: Company Product Type Footprint
3.4.3 Human Low-Pass Whole Genome Sequencing Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Human Low-Pass Whole Genome Sequencing Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Human Low-Pass Whole Genome Sequencing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Human Low-Pass Whole Genome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Human Low-Pass Whole Genome Sequencing Consumption Value Comparison
4.2.1 United States VS China: Human Low-Pass Whole Genome Sequencing Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Low-Pass Whole Genome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Human Low-Pass Whole Genome Sequencing Companies and Market Share, 2018-2023
4.3.1 United States Based Human Low-Pass Whole Genome Sequencing Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023)
4.4 China Based Companies Human Low-Pass Whole Genome Sequencing Revenue and Market Share, 2018-2023
4.4.1 China Based Human Low-Pass Whole Genome Sequencing Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023)
4.5 Rest of World Based Human Low-Pass Whole Genome Sequencing Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Human Low-Pass Whole Genome Sequencing Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Low-Pass Whole Genome Sequencing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
5.2.2 Small Human Low-Through Whole Genome Sequencing (? 5 Mb)
5.3 Market Segment by Type
5.3.1 World Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023)
5.3.2 World Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2029)
5.3.3 World Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Low-Pass Whole Genome Sequencing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Medical
6.2.2 Scientific Research
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023)
6.3.2 World Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2029)
6.3.3 World Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 BGI
7.1.1 BGI Details
7.1.2 BGI Major Business
7.1.3 BGI Human Low-Pass Whole Genome Sequencing Product and Services
7.1.4 BGI Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 BGI Recent Developments/Updates
7.1.6 BGI Competitive Strengths & Weaknesses
7.2 Breda Genetics
7.2.1 Breda Genetics Details
7.2.2 Breda Genetics Major Business
7.2.3 Breda Genetics Human Low-Pass Whole Genome Sequencing Product and Services
7.2.4 Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Breda Genetics Recent Developments/Updates
7.2.6 Breda Genetics Competitive Strengths & Weaknesses
7.3 Azenta Life Sciences
7.3.1 Azenta Life Sciences Details
7.3.2 Azenta Life Sciences Major Business
7.3.3 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Product and Services
7.3.4 Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Azenta Life Sciences Recent Developments/Updates
7.3.6 Azenta Life Sciences Competitive Strengths & Weaknesses
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Details
7.4.2 Thermo Fisher Scientific Major Business
7.4.3 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Product and Services
7.4.4 Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.4.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.5 Psomagen
7.5.1 Psomagen Details
7.5.2 Psomagen Major Business
7.5.3 Psomagen Human Low-Pass Whole Genome Sequencing Product and Services
7.5.4 Psomagen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Psomagen Recent Developments/Updates
7.5.6 Psomagen Competitive Strengths & Weaknesses
7.6 Healgen Scientific
7.6.1 Healgen Scientific Details
7.6.2 Healgen Scientific Major Business
7.6.3 Healgen Scientific Human Low-Pass Whole Genome Sequencing Product and Services
7.6.4 Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Healgen Scientific Recent Developments/Updates
7.6.6 Healgen Scientific Competitive Strengths & Weaknesses
7.7 Agilent Technologies
7.7.1 Agilent Technologies Details
7.7.2 Agilent Technologies Major Business
7.7.3 Agilent Technologies Human Low-Pass Whole Genome Sequencing Product and Services
7.7.4 Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Agilent Technologies Recent Developments/Updates
7.7.6 Agilent Technologies Competitive Strengths & Weaknesses
7.8 Macrogen
7.8.1 Macrogen Details
7.8.2 Macrogen Major Business
7.8.3 Macrogen Human Low-Pass Whole Genome Sequencing Product and Services
7.8.4 Macrogen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Macrogen Recent Developments/Updates
7.8.6 Macrogen Competitive Strengths & Weaknesses
7.9 Veritas Genetics
7.9.1 Veritas Genetics Details
7.9.2 Veritas Genetics Major Business
7.9.3 Veritas Genetics Human Low-Pass Whole Genome Sequencing Product and Services
7.9.4 Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Veritas Genetics Recent Developments/Updates
7.9.6 Veritas Genetics Competitive Strengths & Weaknesses
7.10 Centogene
7.10.1 Centogene Details
7.10.2 Centogene Major Business
7.10.3 Centogene Human Low-Pass Whole Genome Sequencing Product and Services
7.10.4 Centogene Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Centogene Recent Developments/Updates
7.10.6 Centogene Competitive Strengths & Weaknesses
7.11 Nebula Genomics
7.11.1 Nebula Genomics Details
7.11.2 Nebula Genomics Major Business
7.11.3 Nebula Genomics Human Low-Pass Whole Genome Sequencing Product and Services
7.11.4 Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Nebula Genomics Recent Developments/Updates
7.11.6 Nebula Genomics Competitive Strengths & Weaknesses
7.12 CD Genomics
7.12.1 CD Genomics Details
7.12.2 CD Genomics Major Business
7.12.3 CD Genomics Human Low-Pass Whole Genome Sequencing Product and Services
7.12.4 CD Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 CD Genomics Recent Developments/Updates
7.12.6 CD Genomics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Low-Pass Whole Genome Sequencing Industry Chain
8.2 Human Low-Pass Whole Genome Sequencing Upstream Analysis
8.3 Human Low-Pass Whole Genome Sequencing Midstream Analysis
8.4 Human Low-Pass Whole Genome Sequencing Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Human Low-Pass Whole Genome Sequencing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Human Low-Pass Whole Genome Sequencing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Human Low-Pass Whole Genome Sequencing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Human Low-Pass Whole Genome Sequencing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Human Low-Pass Whole Genome Sequencing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Human Low-Pass Whole Genome Sequencing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Human Low-Pass Whole Genome Sequencing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Human Low-Pass Whole Genome Sequencing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Human Low-Pass Whole Genome Sequencing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Human Low-Pass Whole Genome Sequencing Players in 2022
Table 12. World Human Low-Pass Whole Genome Sequencing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Human Low-Pass Whole Genome Sequencing Company Evaluation Quadrant
Table 14. Head Office of Key Human Low-Pass Whole Genome Sequencing Player
Table 15. Human Low-Pass Whole Genome Sequencing Market: Company Product Type Footprint
Table 16. Human Low-Pass Whole Genome Sequencing Market: Company Product Application Footprint
Table 17. Human Low-Pass Whole Genome Sequencing Mergers & Acquisitions Activity
Table 18. United States VS China Human Low-Pass Whole Genome Sequencing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Human Low-Pass Whole Genome Sequencing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Human Low-Pass Whole Genome Sequencing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Human Low-Pass Whole Genome Sequencing Revenue Market Share (2018-2023)
Table 23. China Based Human Low-Pass Whole Genome Sequencing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Human Low-Pass Whole Genome Sequencing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Human Low-Pass Whole Genome Sequencing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Human Low-Pass Whole Genome Sequencing Revenue Market Share (2018-2023)
Table 29. World Human Low-Pass Whole Genome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Human Low-Pass Whole Genome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2029) & (USD Million)
Table 35. BGI Basic Information, Area Served and Competitors
Table 36. BGI Major Business
Table 37. BGI Human Low-Pass Whole Genome Sequencing Product and Services
Table 38. BGI Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. BGI Recent Developments/Updates
Table 40. BGI Competitive Strengths & Weaknesses
Table 41. Breda Genetics Basic Information, Area Served and Competitors
Table 42. Breda Genetics Major Business
Table 43. Breda Genetics Human Low-Pass Whole Genome Sequencing Product and Services
Table 44. Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Breda Genetics Recent Developments/Updates
Table 46. Breda Genetics Competitive Strengths & Weaknesses
Table 47. Azenta Life Sciences Basic Information, Area Served and Competitors
Table 48. Azenta Life Sciences Major Business
Table 49. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Product and Services
Table 50. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Azenta Life Sciences Recent Developments/Updates
Table 52. Azenta Life Sciences Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Product and Services
Table 56. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Psomagen Basic Information, Area Served and Competitors
Table 60. Psomagen Major Business
Table 61. Psomagen Human Low-Pass Whole Genome Sequencing Product and Services
Table 62. Psomagen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Psomagen Recent Developments/Updates
Table 64. Psomagen Competitive Strengths & Weaknesses
Table 65. Healgen Scientific Basic Information, Area Served and Competitors
Table 66. Healgen Scientific Major Business
Table 67. Healgen Scientific Human Low-Pass Whole Genome Sequencing Product and Services
Table 68. Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Healgen Scientific Recent Developments/Updates
Table 70. Healgen Scientific Competitive Strengths & Weaknesses
Table 71. Agilent Technologies Basic Information, Area Served and Competitors
Table 72. Agilent Technologies Major Business
Table 73. Agilent Technologies Human Low-Pass Whole Genome Sequencing Product and Services
Table 74. Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Agilent Technologies Recent Developments/Updates
Table 76. Agilent Technologies Competitive Strengths & Weaknesses
Table 77. Macrogen Basic Information, Area Served and Competitors
Table 78. Macrogen Major Business
Table 79. Macrogen Human Low-Pass Whole Genome Sequencing Product and Services
Table 80. Macrogen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Macrogen Recent Developments/Updates
Table 82. Macrogen Competitive Strengths & Weaknesses
Table 83. Veritas Genetics Basic Information, Area Served and Competitors
Table 84. Veritas Genetics Major Business
Table 85. Veritas Genetics Human Low-Pass Whole Genome Sequencing Product and Services
Table 86. Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Veritas Genetics Recent Developments/Updates
Table 88. Veritas Genetics Competitive Strengths & Weaknesses
Table 89. Centogene Basic Information, Area Served and Competitors
Table 90. Centogene Major Business
Table 91. Centogene Human Low-Pass Whole Genome Sequencing Product and Services
Table 92. Centogene Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Centogene Recent Developments/Updates
Table 94. Centogene Competitive Strengths & Weaknesses
Table 95. Nebula Genomics Basic Information, Area Served and Competitors
Table 96. Nebula Genomics Major Business
Table 97. Nebula Genomics Human Low-Pass Whole Genome Sequencing Product and Services
Table 98. Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Nebula Genomics Recent Developments/Updates
Table 100. CD Genomics Basic Information, Area Served and Competitors
Table 101. CD Genomics Major Business
Table 102. CD Genomics Human Low-Pass Whole Genome Sequencing Product and Services
Table 103. CD Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Human Low-Pass Whole Genome Sequencing Upstream (Raw Materials)
Table 105. Human Low-Pass Whole Genome Sequencing Typical Customers
Table 1. World Human Low-Pass Whole Genome Sequencing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Human Low-Pass Whole Genome Sequencing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Human Low-Pass Whole Genome Sequencing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Human Low-Pass Whole Genome Sequencing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Human Low-Pass Whole Genome Sequencing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Human Low-Pass Whole Genome Sequencing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Human Low-Pass Whole Genome Sequencing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Human Low-Pass Whole Genome Sequencing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Human Low-Pass Whole Genome Sequencing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Human Low-Pass Whole Genome Sequencing Players in 2022
Table 12. World Human Low-Pass Whole Genome Sequencing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Human Low-Pass Whole Genome Sequencing Company Evaluation Quadrant
Table 14. Head Office of Key Human Low-Pass Whole Genome Sequencing Player
Table 15. Human Low-Pass Whole Genome Sequencing Market: Company Product Type Footprint
Table 16. Human Low-Pass Whole Genome Sequencing Market: Company Product Application Footprint
Table 17. Human Low-Pass Whole Genome Sequencing Mergers & Acquisitions Activity
Table 18. United States VS China Human Low-Pass Whole Genome Sequencing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Human Low-Pass Whole Genome Sequencing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Human Low-Pass Whole Genome Sequencing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Human Low-Pass Whole Genome Sequencing Revenue Market Share (2018-2023)
Table 23. China Based Human Low-Pass Whole Genome Sequencing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Human Low-Pass Whole Genome Sequencing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Human Low-Pass Whole Genome Sequencing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Human Low-Pass Whole Genome Sequencing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Human Low-Pass Whole Genome Sequencing Revenue Market Share (2018-2023)
Table 29. World Human Low-Pass Whole Genome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Human Low-Pass Whole Genome Sequencing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Human Low-Pass Whole Genome Sequencing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Human Low-Pass Whole Genome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Human Low-Pass Whole Genome Sequencing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Human Low-Pass Whole Genome Sequencing Market Size by Application (2024-2029) & (USD Million)
Table 35. BGI Basic Information, Area Served and Competitors
Table 36. BGI Major Business
Table 37. BGI Human Low-Pass Whole Genome Sequencing Product and Services
Table 38. BGI Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. BGI Recent Developments/Updates
Table 40. BGI Competitive Strengths & Weaknesses
Table 41. Breda Genetics Basic Information, Area Served and Competitors
Table 42. Breda Genetics Major Business
Table 43. Breda Genetics Human Low-Pass Whole Genome Sequencing Product and Services
Table 44. Breda Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Breda Genetics Recent Developments/Updates
Table 46. Breda Genetics Competitive Strengths & Weaknesses
Table 47. Azenta Life Sciences Basic Information, Area Served and Competitors
Table 48. Azenta Life Sciences Major Business
Table 49. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Product and Services
Table 50. Azenta Life Sciences Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Azenta Life Sciences Recent Developments/Updates
Table 52. Azenta Life Sciences Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Product and Services
Table 56. Thermo Fisher Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Psomagen Basic Information, Area Served and Competitors
Table 60. Psomagen Major Business
Table 61. Psomagen Human Low-Pass Whole Genome Sequencing Product and Services
Table 62. Psomagen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Psomagen Recent Developments/Updates
Table 64. Psomagen Competitive Strengths & Weaknesses
Table 65. Healgen Scientific Basic Information, Area Served and Competitors
Table 66. Healgen Scientific Major Business
Table 67. Healgen Scientific Human Low-Pass Whole Genome Sequencing Product and Services
Table 68. Healgen Scientific Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Healgen Scientific Recent Developments/Updates
Table 70. Healgen Scientific Competitive Strengths & Weaknesses
Table 71. Agilent Technologies Basic Information, Area Served and Competitors
Table 72. Agilent Technologies Major Business
Table 73. Agilent Technologies Human Low-Pass Whole Genome Sequencing Product and Services
Table 74. Agilent Technologies Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Agilent Technologies Recent Developments/Updates
Table 76. Agilent Technologies Competitive Strengths & Weaknesses
Table 77. Macrogen Basic Information, Area Served and Competitors
Table 78. Macrogen Major Business
Table 79. Macrogen Human Low-Pass Whole Genome Sequencing Product and Services
Table 80. Macrogen Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Macrogen Recent Developments/Updates
Table 82. Macrogen Competitive Strengths & Weaknesses
Table 83. Veritas Genetics Basic Information, Area Served and Competitors
Table 84. Veritas Genetics Major Business
Table 85. Veritas Genetics Human Low-Pass Whole Genome Sequencing Product and Services
Table 86. Veritas Genetics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Veritas Genetics Recent Developments/Updates
Table 88. Veritas Genetics Competitive Strengths & Weaknesses
Table 89. Centogene Basic Information, Area Served and Competitors
Table 90. Centogene Major Business
Table 91. Centogene Human Low-Pass Whole Genome Sequencing Product and Services
Table 92. Centogene Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Centogene Recent Developments/Updates
Table 94. Centogene Competitive Strengths & Weaknesses
Table 95. Nebula Genomics Basic Information, Area Served and Competitors
Table 96. Nebula Genomics Major Business
Table 97. Nebula Genomics Human Low-Pass Whole Genome Sequencing Product and Services
Table 98. Nebula Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Nebula Genomics Recent Developments/Updates
Table 100. CD Genomics Basic Information, Area Served and Competitors
Table 101. CD Genomics Major Business
Table 102. CD Genomics Human Low-Pass Whole Genome Sequencing Product and Services
Table 103. CD Genomics Human Low-Pass Whole Genome Sequencing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Human Low-Pass Whole Genome Sequencing Upstream (Raw Materials)
Table 105. Human Low-Pass Whole Genome Sequencing Typical Customers
LIST OF FIGURES
Figure 1. Human Low-Pass Whole Genome Sequencing Picture
Figure 2. World Human Low-Pass Whole Genome Sequencing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Low-Pass Whole Genome Sequencing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Human Low-Pass Whole Genome Sequencing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Human Low-Pass Whole Genome Sequencing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 13. Human Low-Pass Whole Genome Sequencing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Human Low-Pass Whole Genome Sequencing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Human Low-Pass Whole Genome Sequencing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Low-Pass Whole Genome Sequencing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Low-Pass Whole Genome Sequencing Markets in 2022
Figure 27. United States VS China: Human Low-Pass Whole Genome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Low-Pass Whole Genome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Human Low-Pass Whole Genome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type in 2022
Figure 31. Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
Figure 32. Small Human Low-Through Whole Genome Sequencing (? 5 Mb)
Figure 33. World Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2018-2029)
Figure 34. World Human Low-Pass Whole Genome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application in 2022
Figure 36. Medical
Figure 37. Scientific Research
Figure 38. Others
Figure 39. Human Low-Pass Whole Genome Sequencing Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Human Low-Pass Whole Genome Sequencing Picture
Figure 2. World Human Low-Pass Whole Genome Sequencing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Low-Pass Whole Genome Sequencing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Human Low-Pass Whole Genome Sequencing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Human Low-Pass Whole Genome Sequencing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Human Low-Pass Whole Genome Sequencing Revenue (2018-2029) & (USD Million)
Figure 13. Human Low-Pass Whole Genome Sequencing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Human Low-Pass Whole Genome Sequencing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Human Low-Pass Whole Genome Sequencing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Human Low-Pass Whole Genome Sequencing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Low-Pass Whole Genome Sequencing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Low-Pass Whole Genome Sequencing Markets in 2022
Figure 27. United States VS China: Human Low-Pass Whole Genome Sequencing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Low-Pass Whole Genome Sequencing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Human Low-Pass Whole Genome Sequencing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type in 2022
Figure 31. Large Human Low-Through Whole Genome Sequencing (> 5 Mb)
Figure 32. Small Human Low-Through Whole Genome Sequencing (? 5 Mb)
Figure 33. World Human Low-Pass Whole Genome Sequencing Market Size Market Share by Type (2018-2029)
Figure 34. World Human Low-Pass Whole Genome Sequencing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Human Low-Pass Whole Genome Sequencing Market Size Market Share by Application in 2022
Figure 36. Medical
Figure 37. Scientific Research
Figure 38. Others
Figure 39. Human Low-Pass Whole Genome Sequencing Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
